Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients

World Journal of Biological Psychiatry

Volumn 2, Issue 2, 2001, Pages 99-102

  Harris, Debra S ^a   Wolkowitz, Owen M ^a   Reus, Victor I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cortisol; dehydroepiandrosterone (DHEA); memory; movement disorder; schizophrenia

Indexed keywords

CHLORPROMAZINE; HYDROCORTISONE; NEUROLEPTIC AGENT; PRASTERONE;

ADULT; AGED; ARTICLE; BLOOD; BODY POSTURE; FEMALE; HUMAN; MALE; MEMORY DISORDER; MIDDLE AGED; MOTOR DYSFUNCTION; PARKINSONISM; PSYCHOLOGY; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MEMORY DISORDERS; MIDDLE AGED; MOVEMENT DISORDERS; PARKINSONIAN DISORDERS; POSTURE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0035324285     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622970109027500     Document Type: Article

References (23)

1. Baulieu EE (1997) Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res 52:1-32.
2. Berkman LF, Seeman TE, Albert M, Blazer D, Kahn R, Mohs R, Finch C, Schneider E, Cotman C, McClearn G, Nesselroade J, Featherman D, Garmezy N, McKhann G, Brim G, Prager D, Rowe J (1993) High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol 46(10):1129-1140.
3. Bezchlibnyk-Butler KZ, Jeffries JJ (1997) Clinical Handbook of Psychotropic Drugs. Hogrefe & Huber Publishers, Seattle.
4. Bologa L, Sharma J, Roberts E (1987) Dehydroepiandrosterone and its sulphate derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J Neurosci Res 1 7:225-234.
5. Demirgoren S, Majewska MD, Spivak CE, London ED (1991) Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience 45(1):127-135.
6. Erb JL, Kadane JB, Tourney G, Mickelsen R, Trader D, Szabo R, Davis V (1981) Discrimination between schizophrenic and control subjects by means of plasma dehydroepiandrosterone measurements. J Clin Endocrinol Metab 52(2):181-186.
7. Faustman WO, Overall JE (1999) The Brief Psychiatric Rating Scale. In: Maurish M (ed) Use of Psychological Testing for Treatment Planning and Outcome Assessment. Lawrence Erlbaum Associates, Hillsdale, NJ, pp 791-830.
8. Ganzini L, Casey DE, Hoffman WF, Heintz RT (1992) Tardive dyskinesia and diabetes mellitus. Psychopharmacol Bull 28(3):281-286.
9. Garcia de Yebenes E, Hong M, Pelletier G (1995) Effects of dehydroepiandrosterone (DHEA) on pituitary prolactin and arcuate nucleus neuron tyrosine hydroxylase mRNA levels in the rat. J Neuroendocrinol 7(8):589-595.
10. Gerlach J, Korgard S (1993) The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand 87(4):244-252.
11. Herbert J (1998) Neurosteroids, brain damage, and mental illness. Exp Gerontol 33(7/8):713-727.
12. Hollister LE (1973) Clinical Use of Psychotherapeutic Drugs. Charles C Thomas, Springfield, IL.
13. Imamura M, Prasad C (1998) Modulation of GABA-gated chloride ion influx in the brain by dehydroepiandrosterone and its metabolites. Biochem Biophys Res Commun 243(3):771-775.
14. Jeste DV, Caligiuri MP (1993) Tardive dyskinesia. Schizophr Bull 19(2):303-315.
15. Oades RD, Schepker R (1994) Serum gonadal steroid hormones in young schizophrenic patients. Psychoneuroendocrinology 19(4):373-385.
16. Physicians Desk Reference (1997) Medical Economics Company, Inc, Montvale, NJ.
17. Porter JR, Abadie JM, Wright BE, Browne ES, Svec F (1995) The effect of discontinuing dehydroepiandrosterone supplementation on Zucker rat food intake and hypothalamic neurotransmitters. Int J Obes Relat Metab Disord 19(7):480-488.
18. Reus VI, Wolkowitz OM, Roberts E, Chan T, Turetsky N, Manfredi F, Weingartner H (1993) Dehydroepiandrosterone (DHEA) and memory in depressed patients. Neuropsychopharmacology 9:66S.
19. Spivak CE (1994) Desensitization and noncompetitive blockade of GABAA receptors in ventral midbrain neurons by a neurosteroid dehydroepiandrosterone sulfate. Synapse 16(2):113-122.
20. Strauss EB, Sands DE, Robinson AM, Tindall WJ, Stevenson WAH (1952) Use of dehydroisoandrosterone in psychiatric treatment: a preliminary survey. Br Med J 2:64-66.
21. Weingartner HJ, Eckardt M, Molchan S, Sunderland T, Wolkowitz O (1992) Measurement and interpretation of changes in memory in response to drug treatments. Psychopharmacol Bull 28(4):331-340.
22. Woerner MG, Saltz BL, Kane JM, Lieberman JA, Alvir JM (1993) Diabetes and development of tardive dyskinesia. Am J Psychiatry 150(6):966-968.
23. Wolkowitz OM, Reus VI (2000) Neuropsychiatric Effects of Dehydroepiandrosterone (DHEA). In: Kalimi M, Regelson W (eds) Dehydroepiandrosterone (DHEA): Biochemical, Physiological and Clinical Aspects. Walter De Gruyter, Berlin, pp 271-298.